TY - JOUR
AU1 - Lipani, Luca
AU2 - Dupont, Bertrand
AU3 - Doungmene, Floriant
AU4 - Marken, Frank
AU5 - Tyrrell, Rex
AU6 - Guy, Richard
AU7 - Ilie, Adelina
AB - Currently, there is no available needle-free approach for diabetics to monitor glucose levels in the interstitial fluid. Here, we report a path-selective, non-invasive, transdermal glucose monitoring system based on a miniaturized pixel array platform (realized either by graphene-based thin-film technology, or screen-printing). The system samples glucose from the interstitial fluid via electroosmotic extraction through individual, privileged, follicular pathways in the skin, accessible via the pixels of the array. A proof of principle using mammalian skin ex vivo is demonstrated for specific and ‘quantized’ glucose extraction/detection via follicular pathways, and across the hypo- to hyper-glycaemic range in humans. Furthermore, the quantification of follicular and non-follicular glucose extraction fluxes is clearly shown. In vivo continuous monitoring of interstitial fluid-borne glucose with the pixel array was able to track blood sugar in healthy human subjects. This approach paves the way to clinically relevant glucose detection in diabetics without the need for invasive, finger-stick blood sampling.
TI - Non-invasive, transdermal, path-selective and specific glucose monitoring via a graphene-based platform
JF - Nature Nanotechnology
DO - 10.1038/s41565-018-0112-4
DA - 2018-04-09
UR - https://www.deepdyve.com/lp/springer-journals/non-invasive-transdermal-path-selective-and-specific-glucose-hzlWpvRdHZ
SP - 504
EP - 511
VL - 13
IS - 6
DP - DeepDyve
ER -